DON LYNN GIBBONS to CTLA-4 Antigen
This is a "connection" page, showing publications DON LYNN GIBBONS has written about CTLA-4 Antigen.
Connection Strength
0.364
-
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. Nature. 2024 Nov; 635(8038):462-471.
Score: 0.177
-
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance. Front Immunol. 2023; 14:1161869.
Score: 0.162
-
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set. BMC Med. 2016 10 25; 14(1):168.
Score: 0.025